Heparin Sodium Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Heparin Sodium Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 11/14/2017.
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-7620-59
- Dosage Form
- Injection
- Presentation
- Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-7620-59)
- Initial Posting
- 11/14/2017
- Revised Date